Trials / Withdrawn
WithdrawnNCT00000193
Neurobiology of Opioid Dependence: 2 - 2
Neurobiology of Opioid Dependence: 2
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gamma hydroxybutyric |
Timeline
- Start date
- 1993-01-01
- Primary completion
- 1998-01-01
- Completion
- 1998-01-01
- First posted
- 1999-09-21
- Last updated
- 2015-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000193. Inclusion in this directory is not an endorsement.